-
Global COVID-19 Clinical Platform: Rapid Core Case Report Form (CRF)
Source: World Health Organization (WHO)Date Published: 7/13/2020Format: PDFAnnotation: The eight-page, three-module COVID-19 Rapid Core Case Report Form (CRF) is designed to collect data obtained through examination, interview, and review of hospital notes. Data may be collected prospectively or retrospectively.
In response to the COVID-19 pandemic, the World Health Organization (WHO) has launched a global COVID-19 anonymized clinical data platform (the “COVID-19 Data Platform”) to enable State Parties to the International Health Regulations (IHR) (2005) to share with WHO anonymized clinical data related to patients with suspected or confirmed infections with SARS-CoV-2 (collectively “anonymized COVID-19 data”). The anonymized COVID-19 data received by WHO will remain the property of the contributing Entity and will be used by WHO for purposes of verification, assessment and assistance pursuant to the IHR (2005), including to inform the public health and clinical operation response in connection with the COVID-19 outbreak. To help achieve these objectives, WHO has established an independent Clinical Advisory Group to advise WHO on global reporting and analysis of the anonymized clinical COVID-19 data. State Parties and other entities are invited to contact WHO to obtain more information about how to contribute anonymized clinical COVID-19 data to the WHO Data Platform. To preserve the security and confidentiality of the anonymized COVID-19 data, State Parties and other entities are respectfully requested to take all necessary measures to protect their respective log-in credentials and passwords to the COVID-19 Data Platform.
The anonymized COVID-19 data will be stored in the WHO COVID-19 Data Platform, which is a secured, access-limited, password protected electronic platform. WHO will (i) protect the confidentiality and prevent the unauthorized disclosure of the anonymized COVID-19 data; (ii) implement and maintain appropriate technical and organizational security measures to protect the security of the anonymized COVID-19 data and the COVID-19 Data Platform. In accordance with Article 11(4) of the IHR (2005), WHO will not make the anonymized COVID-19 data generally available to other State Parties or entities until such time as any of the conditions set forth in paragraph 2 of Article 11 are first met, and following consultation with affected countries/entities. Pursuant to that same Article 11, WHO will not make the anonymized COVID-19 data available to the public, unless and until the anonymized COVID-19 data have already been made available to State Parties, and provided that other information about the COVID-19 epidemic has already become publicly available and there is a need for the dissemination of authoritative and independent information. To contribute data to the WHO COVID-19 Data Platform or to receive more information, please contact: COVID_ClinPlatform@who.int.
The Rapid Core CRF is designed to collect data obtained through examination, interview and review of hospital notes. Data may be collected prospectively or retrospectively. The data collection period is defined as the period from hospital admission to discharge, transfer, death, or continued hospitalization without possibility of continued data collection.
This CRF has 3 modules:
Module 1: to be completed on the first day of admission to the health centre.
Module 2: to be completed daily during hospital stay for as many days as resources allow. Continue to follow-up patients who transfer between wards.
Module 3: to be completed at discharge or death.
Population: All/Anyone
Length: 19 items
Mode of Administration: Pen and Paper
Administered by: Specialist/Doctor/Expert
Language(s): English...[See more] [See less]Type: Guideline/Assessment ToolAccess Notes: Direct link to document: https://apps.who.int/iris/rest/bitstreams/1287200/retrieve
Free/Publicly Available
Contact: World Health Organization (WHO), COVID_ClinPlatform@who.intIncludes Research Tools: Yes.ID: 23004. From: Disaster Lit®a database of the U.S. National Library of Medicine. -
Global COVID-19 Clinical Platform with Pregnancy Module – CRF-P
Source: World Health Organization (WHO)Date Published: 7/13/2020Format: PDFAnnotation: This 13-page Pregnancy Module Case Report Form (CRF-P) should be completed for pregnant women or recently pregnant women who delivered within 21 days from onset of COVID-19 symptoms. Data may be collected retrospectively if the patient data are obtained after the admission date.
In response to the COVID-19 pandemic, the World Health Organization (WHO) has launched a global COVID-19 anonymized clinical data platform (the “COVID-19 Data Platform”) to enable State Parties to the International Health Regulations (IHR) (2005) to share with WHO anonymized clinical data related to patients with suspected or confirmed infections with SARS-CoV-2 (collectively “anonymized COVID-19 data”). The anonymized COVID-19 data received by WHO will remain the property of the contributing Entity and will be used by WHO for purposes of verification, assessment and assistance pursuant to the IHR (2005), including to inform the public health and clinical operation response in connection with the COVID-19 outbreak. To help achieve these objectives, WHO has established an independent Clinical Advisory Group to advise WHO on global reporting and analysis of the anonymized clinical COVID-19 data. State Parties and other entities are invited to contact WHO to obtain more information about how to contribute anonymized clinical COVID-19 data to the WHO Data Platform. To preserve the security and confidentiality of the anonymized COVID-19 data, State Parties and other entities are respectfully requested to take all necessary measures to protect their respective log-in credentials and passwords to the COVID-19 Data Platform.
The anonymized COVID-19 data will be stored in the WHO COVID-19 Data Platform, which is a secured, access-limited, password protected electronic platform. WHO will (i) protect the confidentiality and prevent the unauthorized disclosure of the anonymized COVID-19 data; (ii) implement and maintain appropriate technical and organizational security measures to protect the security of the anonymized COVID-19 data and the COVID-19 Data Platform. In accordance with Article 11(4) of the IHR (2005), WHO will not make the anonymized COVID-19 data generally available to other State Parties or entities until such time as any of the conditions set forth in paragraph 2 of Article 11 are first met, and following consultation with affected countries/entities. Pursuant to that same Article 11, WHO will not make the anonymized COVID-19 data available to the public, unless and until the anonymized COVID-19 data have already been made available to State Parties, and provided that other information about the COVID-19 epidemic has already become publicly available and there is a need for the dissemination of authoritative and independent information. To contribute data to the WHO COVID-19 Data Platform or to receive more information, please contact: COVID_ClinPlatform@who.int.
The CRF is designed to collect data obtained through examination, interview and review of hospital notes. Data may be collected retrospectively if the patient data are obtained after the admission date. The data collection period is defined as the period from hospital admission to discharge, transfer, death, or continued hospitalization without possibility of continued data collection. This CRF-P should be completed for pregnant women or recently pregnant women who delivered within 21 days from onset of symptoms. If COVID symptoms started more than 21 days after the end of the pregnancy, please complete the Rapid Core CRF only.
The Pregnancy CRF has 3 sections:
Module 1: to be completed on the first day of admission to the health centre.
Module 2: to be completed daily during hospital stay for as many days as resources allow. Continue to follow-up patients who transfer between wards.
Module 3: to be completed at discharge or death.
Population: Pregnant or Lactating Women; High Risk/Special/Unique Populations
Length: 33 items
Mode of Administration: Pen and Paper
Administered by: Specialist/Doctor/Expert
Language(s): English
WHO Global COVID-19 Clinical Platform: Pregnancy Case Report Form (CRF): Full questionnaire https://www.phenxtoolkit.org/toolkit_content/PDF/WHO_Pregnancy_CRF.pdf
Hospital Admission Case Record Form: General Symptoms; Diagnosis; Personal Demographics https://www.phenxtoolkit.org/toolkit_content/PDF/WHO_Pregnancy_CRF_Admission.pdf
Daily Case Record Form: General Symptoms; Diagnosis https://www.phenxtoolkit.org/toolkit_content/PDF/WHO_Pregnancy_CRF_Daily.pdf
Treatment and Outcome Case Record Form: Treatment; Outcomes https://www.phenxtoolkit.org/toolkit_content/PDF/WHO_Pregnancy_CRF_Treatment.pdf...[See more] [See less]Type: Guideline/Assessment ToolAccess Notes: Direct link to document: https://apps.who.int/iris/rest/bitstreams/1287196/retrieve
Free/Publicly Available
Contact: World Health Organization (WHO), COVID_ClinPlatform@who.intIncludes Research Tools: Yes.ID: 23005. From: Disaster Lit®a database of the U.S. National Library of Medicine. -
Global COVID-19 Clinical Platform: Case Report Form for Suspected Cases of Multisystem Inflammatory Syndrome (MIS) in Children and Adolescents Temporally Related to COVID-19
Source: World Health Organization (WHO)Date Published: 6/1/2020Format: PDFAnnotation: This eight-page form, updated on June 1, 2020, is to be completed for all children aged 0–19 suspected to have multisystem inflammatory disorder temporally related to COVID-19 (even if all criteria in the case definition are not met – to capture full spectrum of the condition).
Population: Children/Teens Only
Length: 15 items
Mode: Pen and Paper
Administered by: Specialist/Doctor/Expert
Language(s): English, Arabic, Chinese, French, Russian, Spanish
Global COVID-19 Clinical Platform: Case Report Form for Suspected Cases of Multisystem Inflammatory Syndrome (MIS) in Children and Adolescents Temporally Related to COVID-19: Full Questionnaire https://www.phenxtoolkit.org/toolkit_content/PDF/WHO_MIS.pdf
Hospital Admission Case Record Form: General Symptoms; Diagnosis; Personal Demographics https://www.phenxtoolkit.org/toolkit_content/PDF/WHO_MIS_Admission.pdf
Treatment and Outcome Case Record Form: General Symptoms; Treatment; Outcomes https://www.phenxtoolkit.org/toolkit_content/PDF/WHO_MIS_Treatment.pdf...[See more] [See less]Type: Guideline/Assessment ToolAccess Notes: Direct link to document: https://apps.who.int/iris/rest/bitstreams/1279054/retrieve
Link to document in Arabic: https://apps.who.int/iris/bitstream/handle/10665/332121/WHO-2019-nCoV-MIS_Children_CRF-2020.1-ara.pdf?sequence=7&isAllowed=y
Link to document in Chinese: https://apps.who.int/iris/bitstream/handle/10665/332121/WHO-2019-nCoV-MIS_Children_CRF-2020.1-chi.pdf?sequence=19&isAllowed=y
Link to document in French: https://apps.who.int/iris/bitstream/handle/10665/332270/WHO-2019-nCoV-MIS_Children_CRF-2020.1-fre.pdf?sequence=1&isAllowed=y
Link to document in Russian: https://apps.who.int/iris/bitstream/handle/10665/332121/WHO-2019-nCoV-MIS_Children_CRF-2020.1-rus.pdf?sequence=12&isAllowed=y
Link to document in Spanish: https://apps.who.int/iris/bitstream/handle/10665/332314/WHO-2019-nCoV-MIS_Children_CRF-2020.1-spa.pdf?sequence=1&isAllowed=yID: 22232. From: Disaster Lit®a database of the U.S. National Library of Medicine. -
Population-Based Age-Stratified Seroepidemiological Investigation Protocol for COVID-19 Virus Infection
Source: World Health Organization (WHO)Date Published: 3/17/2020Format: PDFAnnotation: This 19-page protocol has been designed to investigate the extent of infection, as determined by seropositivity in the general population, in any country in which COVID-19 (coronavirus) infection has been reported. Each country may need to tailor some aspects of this protocol to align with public health, laboratory, and clinical systems, according to capacity, availability of resources, and cultural appropriateness.
Population: All/Anyone
Length: 4 questions
Administered by: Self Administered/Self Report; Trained Lay Examiner/Interviewer
Language(s): English...[See more] [See less]Type: Guideline/Assessment ToolAccess Notes: Free/Publicly Available
Contact Information: Trained Lay Examiner/InterviewerIncludes Research Tools: Yes.ID: 21220. From: Disaster Lit®a database of the U.S. National Library of Medicine. -
Household Transmission Investigation Protocol for 2019-Novel Coronavirus (COVID-19) Infection
Source: World Health Organization (WHO)Date Published: 2/28/2020Format: PDFAnnotation: This 31-page household transmission investigation is a case-ascertained prospective study of all identified household contacts of a laboratory confirmed 2019-novel coronavirus (2019-nCoV) infection. It is intended to provide rapid and early information on the clinical, epidemiological, and virological characteristics of 2019-nCoV. The protocol has been designed to investigate household transmission of 2019-nCoV in any country in which 2019-nCoV infection has been reported and households are exposed.
Population: All/Anyone
Length: 29 items
Administered by: Specialist/Doctor/Expert
Language(s): English...[See more] [See less]Type: Study Design/ProtocolAccess Notes: Direct link to document: https://apps.who.int/iris/rest/bitstreams/1272252/retrieve
Permission/Request required
Contact Information: EarlyInvestigations-2019-nCoV@who.int, godata@who.intIncludes Research Tools: Yes.ID: 20698. From: Disaster Lit®a database of the U.S. National Library of Medicine. -
Surface Sampling of Coronavirus Disease (COVID-19): A Practical “How To” Protocol for Health Care and Public Health Professionals
Source: World Health Organization (WHO)Date Published: 2/18/2020Format: PDFAnnotation: This 26-page protocol has been designed to determine (viable) virus presence and persistence on fomites in various locations where a patient infected with COVID-19 (2019 novel coronavirus) is currently receiving care or being isolated, and to understand how this may relate to COVID-19 transmission events in these settings. It is therefore important that it is done as part of a comprehensive outbreak investigation and that information obtained by environmental studies is combined with the results of epidemiological, laboratory, and sequence data from COVID-19 patient investigations.
Population: Adults only
Administered by: Specialist/Doctor/Expert
Language(s): English...[See more] [See less]Type: Guideline/Assessment ToolAccess Notes: Permission/Request required
Contact Information: World Health Organization (WHO)Includes Research Tools: Yes.ID: 20894. From: Disaster Lit®a database of the U.S. National Library of Medicine. -
First Few X (FFX) Cases and Contact Investigation Protocol for 2019-Novel Coronavirus (2019-nCoV) Infection, Version 2
Source: World Health Organization (WHO)Date Published: 2/10/2020Format: PDFAnnotation: This 65-page protocol, updated on February 2, 2020, has been designed to investigate the First Few X (FFX) cases of 2019 novel coronavirus (2019-nCoV) and their close contacts. It is envisioned that the FFX 2019-nCoV investigation will be conducted across several countries or sites with geographical and demographic diversity. Using a standardized protocol such as the protocol provided here, epidemiological exposure data and biological samples can be systematically collected and shared rapidly in a format that can be easily aggregated, tabulated, and analyzed across many different settings globally for timely estimates of 2019-nCoV infection severity and transmissibility, as well as to inform public health responses and policy decisions.
Population: All/Anyone
Length: 6 items
Administered by: Specialist/Doctor/Expert
Language(s): English...[See more] [See less]Type: Study Design/ProtocolAccess Notes: Free/Publicly Available
Contact Information: godata@who.int, https://www.who.int/godataIncludes Research Tools: Yes.ID: 20719. From: Disaster Lit®a database of the U.S. National Library of Medicine. -
Protocol for Assessment of Potential Risk Factors for 2019-Novel Coronavirus (2019-nCoV) Infection Among Health Care Workers in a Health Care Setting
Source: World Health Organization (WHO)Date Published: 1/25/2020Format: PDFAnnotation: This 32-page document is a case-ascertained prospective investigation of all identified health care contacts working in a health care facility in which a laboratory confirmed 2019-nCoV infected patient receives care. This study can be done in health care facilities at all three levels of a health system, not just in hospitals. It is intended to provide epidemiological and serologic information that will inform the identification of risk factors 2019-nCoV infection among health care workers.
Population: First Responders, Emergency Medical Services (EMS) Personnel, Police/Fire Departments, Healthcare workers
Length: 12 questions and a 21-day diary
Administered by: Self Administered/Self Report; Trained Lay Examiner/Interviewer
Special Considerations: Form 1: "Report Form for health care worker" is completed by worker. Form 2: "Report Form for health care worker" is completed by worker and study coordinator. Form 3: "Laboratory results" is completed by study coordinator. Form 4: "Symptom diary" is complted by worker. Form 5: "Health care facility infection prevention and control" is filled out by a health care facility administrator once for every
health care facility involved in the investigation.
Language(s): English...[See more] [See less]Type: Study Design/ProtocolAccess Notes: Direct link to document: https://www.who.int/docs/default-source/inaugural-who-partners-forum/20200131-2019-ncov-health-care-worker-protocol-v1.pdf?sfvrsn=a2b876f8_0&download=true
Permission/Request required
Contact Information: World Health Organization (WHO); godata@who.intIncludes Research Tools: Yes.ID: 20741. From: Disaster Lit®a database of the U.S. National Library of Medicine. -
Alcohol Use Disorders Identification Test (AUDIT)
Source: World Health Organization (WHO)Date Published: 1982Format: PDFAnnotation: The Alcohol Use Disorders Identification Test (AUDIT) is a 10-item questionnaire that screens for hazardous or harmful alcohol consumption and identifies mild dependence. Developed by the World Health Organization (WHO), the test correctly classifies 95 percent of people into either alcoholics or non-alcoholics. The AUDIT is particularly suitable for use in primary care settings and has been used with a variety of populations and cultural groups. It should be administered by a health professional or paraprofessional. This resource was identified by the NIH Disaster Research Response Program (DR2) for researchers looking for pre- and post-disaster data collection instruments.
Ease of Use in Disaster Setting: Easy
Flesch-Kincaid Reading Level: Grade 8.9
Population: All/Anyone
Length: 10 questions
Time to Complete: 2-4 Minutes
Administered by: Self Administered/Self Report, Lay Interviewer, Specialist/Doctor/Expert
Language(s): English, Spanish, Slavic, Chinese, Catalan, Dutch, French, Japanese, Portuguese, Russian, Slovenian, Swedish, Polish, Norwegian, Swahili, and Romanian
These translations are available by writing to the Programme on Substance Abuse, World Health Organization, 1211 Geneva 27, Switzerland; some translations may also be found at: http://www.alcohollearningcentre.org.uk/Topics/Browse/BriefAdvice/?parent=4444&child=6148...[See more] [See less]Type: Guideline/Assessment ToolAccess Notes: Free/Publicly Available
Citation(s):
MacFarlane AC, Van Hoff M. Impact of childhood exposure to a natural disaster on adult mental health: 20-year longitudinal follow-up study. Br J Psychiatry. 2009 Aug;195(2):142-8. PubMed PMID: 19648546. https://www.ncbi.nlm.nih.gov/pubmed/19648546. Subscription not required.
Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction. 1993 Jun;88(6):791-804. PubMed PMID: 8329970. https://www.ncbi.nlm.nih.gov/pubmed/8329970. Subscription required.
Bohn MJ, Babor TF, Kranzler HR. The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings. J Stud Alcohol. 1995 Jul;56(4):423-32. PubMed PMID: 7674678. https://www.ncbi.nlm.nih.gov/pubmed/7674678. Subscription required.
Schmidt A, Barry KL, Fleming MF. Detection of problem drinkers: the Alcohol Use Disorders Identification Test (AUDIT). South Med J. 1995 Jan;88(1):52-9. PubMed PMID: 7817228. https://www.ncbi.nlm.nih.gov/pubmed/7817228. Subscription required.
Conigrave KM, Hall WD, Saunders JB. The AUDIT questionnaire: choosing a cut-off score. Alcohol Use Disorder Identification Test. Addiction. 1995 Oct;90(10):1349-56. PubMed PMID: 8616463. https://www.ncbi.nlm.nih.gov/pubmed/8616463. Subscription required.
Available Formats: Electronic
Contact information:
Substance Abuse and Mental Health Services Administration/ Department of Health and Human Services
http://www.integration.samhsa.gov/clinical-practice/screening-tools
World Health Organization, Department of Mental Health and Substance Dependence
https://apps.who.int/iris/bitstream/handle/10665/67205/WHO_MSD_MSB_01.6a.pdf?sequence=1
Public Health England (PHE)
http://www.alcohollearningcentre.org.uk/Topics/Browse/BriefAdvice/?parent=4444&child=4896Includes Research Tools: Yes.ID: 8991. From: Disaster Lit®a database of the U.S. National Library of Medicine. -
World Mental Health: Composite International Diagnostic Interview
Source: World Health Organization (WHO)Format: TextAnnotation: The Composite International Diagnostic Interview (CIDI) is a comprehensive, fully-structured interview designed to be used by trained lay interviewers for the assessment of mental disorders according to the definitions and criteria of the ICD-10 (International Classification of Diseases, 10th Revision) and DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, 4th Edition). It is intended for use in epidemiological and cross-cultural studies, as well as for clinical and research purposes. The diagnostic section of the interview is based on the World Health Organization (WHO)'s Composite. This resource was identified by the NIH Disaster Research Response Program (DR2) for researchers looking for pre- and post-disaster data collection instruments.
Ease of Use in Disaster Setting: Difficult
Population: Adults Only
Length: Highly dependent upon modules selected for use. There are 42 modules of varying lengths. The CIDI-Core contains 20 major questions and 59 sub-questions, and takes approximately 75 minutes to administer, including all possible sub-questions.
Time to Complete: Approximately two hours for most general population samples. Total time to administer is highly variable and dependent upon the modules selected for use, whether the interviewee screens positive for a module, and the population being studied (certain populations may require the use of optional/additional modules).
Administered by: Lay Interviewer, Specialist/Doctor/Expert
Special Considerations: Training at an official CIDI Training and Reference Center (TRC) is required to use the CIDI. This is true whether you want to use only a single section or the entire instrument. Training is offered on a regular schedule, and you can sign up as an individual trainee, in which case you will have to travel to a TRC for the training. If you have a group of people who need to be trained, you can arrange for CIDI trainers to come to your site for a special training session. Training is three to five days in classroom, plus 30 hours of home study. There is a certification assessment at the end of the in-person training; only trainees who pass this assessment are approved as certified WHO WMH-CIDI users.
Language(s): English, Arabic, Spanish, and Dutch; contact publisher for guidance and translations for other languages....[See more] [See less]Type: Guideline/Assessment ToolAccess Notes: Proprietary - Training Required
Citation(s):
Meewisse ML, Olff M, Kleber R, Kitchiner NJ, Gersons BP. The course of mental health disorders after a disaster: predictors and comorbidity. J Trauma Stress. 2011 Aug;24(4):405-13. Epub 2011 Aug 3. PubMed PMID: 21815216. https://www.ncbi.nlm.nih.gov/pubmed/21815216. Subscription required.
Wittchen HU, Robins LN, Cottler LB, Sartorius N, Burke JD, Regier D. Cross-cultural feasibility, reliability and sources of variance of the Composite International Diagnostic Interview (CIDI). The Multicentre WHO/ADAMHA Field Trials. Br J Psychiatry. 1991 Nov;159:645-53, 658. Erratum in: Br J Psychiatry 1992 Jan;160:136. PubMed PMID: 1756340. https://www.ncbi.nlm.nih.gov/pubmed/1756340. Subscription required.
Wittchen HU. Reliability and validity studies of the WHO--Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res. 1994 Jan-Feb;28(1):57-84. Review. PubMed PMID: 8064641. https://www.ncbi.nlm.nih.gov/pubmed/8064641. Subscription required.
Kessler RC, Ustun TB. World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res. 2004; 13(2):93-121.Includes Research Tools: Yes.ID: 8058. From: Disaster Lit®a database of the U.S. National Library of Medicine.
of 2
Next